Literature DB >> 20177998

The generation of GLP-grade human embryonic stem cell banks from four clinical-grade cell lines for preclinical research.

Shirani Sivarajah1, Grace Selva Raj, Adam Joshua Varughese Mathews, Norliza Binte Esmail Sahib, Wei Sek Hwang, Jeremy Micah Crook.   

Abstract

The Singapore Stem Cell Bank has generated human embryonic stem cell banks from clinical-grade cell lines ESI-017, ESI-035, ESI-049, and ESI-053. All banks were prepared and characterized according to principles of Good Laboratory Practice for quality assurance. Importantly, each cell line has clearly documented and approved ethical provenance and meets recognized standards for performance and safety. The banks are intended to facilitate the translation of stem cell research to clinical medicine by enabling early phase research and development with high-quality, low-cost cells that are also available as clinical-grade stocks.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20177998     DOI: 10.1007/s11626-010-9287-1

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  1 in total

1.  The generation of six clinical-grade human embryonic stem cell lines.

Authors:  Jeremy Micah Crook; Teija Tuulikki Peura; Lucy Kravets; Alexis Gina Bosman; Jeremy James Buzzard; Rachel Horne; Hannes Hentze; Norris Ray Dunn; Robert Zweigerdt; Florence Chua; Alan Upshall; Alan Colman
Journal:  Cell Stem Cell       Date:  2007-11       Impact factor: 24.633

  1 in total
  5 in total

Review 1.  Infectious problems associated with transplantation of cells differentiated from pluripotent stem cells.

Authors:  Outi Hovatta
Journal:  Semin Immunopathol       Date:  2011-04-09       Impact factor: 9.623

Review 2.  The International Stem Cell Banking Initiative (ISCBI): raising standards to bank on.

Authors:  Jeremy Micah Crook; Derek Hei; Glyn Stacey
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-03-03       Impact factor: 2.416

Review 3.  Therapeutic effects of stem cells in rodent models of Huntington's disease: Review and electrophysiological findings.

Authors:  Sandra M Holley; Talia Kamdjou; Jack C Reidling; Brian Fury; Dane Coleal-Bergum; Gerhard Bauer; Leslie M Thompson; Michael S Levine; Carlos Cepeda
Journal:  CNS Neurosci Ther       Date:  2018-03-06       Impact factor: 5.243

Review 4.  The use of pluripotent stem cell for personalized cell therapies against neurological disorders.

Authors:  Hye-Yeong Ha; Si-Hyong Jang; Ji-Won Jung
Journal:  J Biomed Biotechnol       Date:  2011-12-13

Review 5.  Challenges to the clinical application of pluripotent stem cells: towards genomic and functional stability.

Authors:  Xuemei Fu; Yang Xu
Journal:  Genome Med       Date:  2012-06-28       Impact factor: 11.117

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.